Kalinchenko Natalia Yu, Kolodkina Anna A, Raygorodskaya Nadezda Y, Tiulpakov Anatoly N
Endocrinology Research Center.
V.I. Razumovskiy Saratov State Medical University.
Probl Endokrinol (Mosk). 2020 Sep 16;66(3):62-69. doi: 10.14341/probl12445.
Steroidogenic factor 1 (SF1, NR5A1) is a nuclear receptor that regulates multiple genes involved in adrenal and gonadal development, steroidogenesis, and the reproductive axis. Human mutations in SF1 were initially found in patients with severe gonadal dysgenesis and primary adrenal failure. However, more recent case reports have suggested that heterozygous mutations in SF1 may also be found in patients with 46,XY partial gonadal dysgenesis and underandrogenization but normal adrenal function. We have analyzed the gene encoding SF1 (NR5A1) in a cohort of 310 Russian patients with 46,XY disorders of sex development (DSD). Heterozygous SF1 variants were found in 36 out of 310 (11.6%) of cases, among them 15 were not previously described. We have not found any phenotype-genotype correlations and any clinical and laboratory markers that would allow to suspect this type of before conducting molecular genetic analysis.
类固醇生成因子1(SF1,NR5A1)是一种核受体,可调节参与肾上腺和性腺发育、类固醇生成及生殖轴的多个基因。SF1的人类突变最初在患有严重性腺发育不全和原发性肾上腺功能衰竭的患者中发现。然而,最近的病例报告表明,在46,XY部分性腺发育不全和雄激素化不足但肾上腺功能正常的患者中也可能发现SF1的杂合突变。我们分析了310名患有46,XY性发育障碍(DSD)的俄罗斯患者队列中编码SF1(NR5A1)的基因。在310例病例中有36例(11.6%)发现了杂合SF1变异体,其中15例此前未被描述。我们未发现任何表型-基因型相关性以及任何临床和实验室标志物可在进行分子遗传学分析之前怀疑此类情况。